Efficacy and safety of Danlou tablets in traditional Chinese medicine for coronary heart disease: a systematic review and meta-analysis

BackgroundDanlou tablets exert auxiliary advantages in treating coronary heart disease (CHD), but a summary of evidence-based proof is lacking. This study aims to systematically evaluate Danlou tablets in treating CHD from two aspects, including efficacy and safety.MethodsBy a thorough retrieval of the four English databases, namely, PubMed, The Cochrane Library, Embase, and Web of Science, and the four Chinese databases, namely, CNKI, Wanfang, VIP database, and China Biomedical Literature Service System, we found all randomized controlled trials (RCTs) related to Danlou tablets in treating CHD. The retrieval time was from the construction of the database to April 2022. We engaged two researchers to screen the studies, extract the required data, and assess the risk of bias. We then used RevMan5.3 and STATA.14 software to conduct a meta-analysis. The Grading of Recommendations Assessment, Development, and Evaluation (GRADE) was used to evaluate the quality of outcome indicators.ResultsSeventeen RCTs involving 1,588 patients were included. The meta-analysis results are displayed as follows: clinical treatment effect [risk ratio (RR) = 1.22, 95% confidence interval (CI): 1.16, 1.28, P < 0.00001], angina pectoris duration [MD = −0.2.15, 95% CI: −2.91, −1.04, P < 0.00001], angina pectoris frequency [standard mean difference (SMD) = −2.48, 95% CI: −3.42, −1.54, P < 0.00001], angina pectoris degree [SMD = −0.96, 95% CI: −1.39, −0.53, P < 0.0001], TC [MD = −0.71, 95% CI: −0.92, −0.51, P < 0.00001], TG [MD = −0.38, 95% CI: −0.53, −0.22, P < 0.00001], low-density lipoprotein cholesterol [MD = −0.64, 95% CI: −0.76, −0.51, P < 0.00001], high-density lipoprotein cholesterol [MD = 0.16, 95% CI: 0.11, 0.21, P < 0.00001], and adverse events [RR = 0.46, 95% CI: 0.24, 0.88, P = 0.02].ConclusionThe current evidence suggests that the combination of Danlou tablets and Western medicine can enhance the efficacy of CHD and does not increase adverse events. However, because of the limited number and quality of the included studies, the results of our study should be treated with caution. Further large-scale RCTs are necessary to verify the benefits of this approach

Effects of traditional qigong exercise on ankylosing spondylitis: a protocol for systematic reviews and meta-analysis

Introduction Ankylosing spondylitis (AS) is a recurrent autoimmune disease that is associated with a high disability rate, which has a profound negative impact on daily life. It has been clinically reported that traditional qigong exercise has certain therapeutic advantages in treating AS; however, this postulation is not evidence-based. Therefore, this study will aim at systematically appraising the validity and safety of traditional qigong exercise in treating AS.Methods and analysis We searched the English (PubMed, Embase, Web of Science and the Cochrane Library) and Chinese databases (China National Knowledge Infrastructure, Wan fang, VIP and Chinese biomedical database) for relevant information. Additionally, the Baidu Academic and Google Academic databases were manually searched to mine relevant information. Randomised controlled clinical trials of traditional qigong exercise in treating AS were searched from the establishment of the database to September 2020. Quality articles were extracted and independently evaluated by two researchers before inclusion in this study. Meta-analysis of the included articles was performed using the RevMan V.5.3 software.Ethics and dissemination This study will not involve primary data collection, and formal ethics approval will, therefore, not be required. We aim to publish this systematic review in a peer-reviewed journal.Trial registration number CRD42020207057

Metal-carbonate interface promoted activity of Ag/MgCO₃ catalyst for aqueous-phase formaldehyde reforming into hydrogen

Aqueous-phase reforming of biomass-derived formaldehyde is one of efficient and sustainable routes to generate molecular hydrogen as clean energy resource. In this work, Ag/MgCO3 catalyst is prepared with constructed stable carbonate-modified metal-support interfaces. Under mild and neutral reaction conditions, it exhibits a near an order of magnitude higher low-temperature activity in formaldehyde reforming reaction for producing hydrogen in comparison with Ag/MgO. The catalytic and spectral observations reveal that the Ag/MgCO3-catalyzed reaction follows an O2-involved HCHO/H2O reforming reaction pathway through O2[rad]−, [rad]OOH and [rad]H radicals as highly active intermediates. Ag/MgCO3 catalyst shows high rates in isotopic H2-D2 exchange and HCHO/D2O reforming reactions and displays an apparent activation energy (Ea) as low as 7.5 kJ mol−1 within 10–50 °C, indicating facile activation of HCHO C[sbnd]H and H2O O[sbnd]H bonds. Furthermore, Ag/MgCO3 catalyst adsorbs HCHO molecule in a favorable configuration and strength, as evidenced by the HCHO desorption profile. Comprehensive positive factors benefit to the superior hydrogen production activity of carbonate-modified Ag/MgCO3 than Ag/MgO.We thank National Natural Science Foundation of China (22178161), Postdoctoral Science Foundation of China (2022 M711597), and National Key R&D Program of China (2018YFE0122600) for the financial support